Our Science – Green Website
Jeffrey E. Green, M.D.
Selected Publications |
 |
| 1)
Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE. Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Res. 14: R109, 2012. [Journal] |
|
| 2)
Chu IM, Michalowski AM, Hoenerhoff M, Szauter KM, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green JE. GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells. Oncogene. 31: 2017-27, 2012. [Journal] |
|
| 3)
Paolicchi E, Crea F, Farrar WL, Green JE, Danesi R. Histone lysine demethylases in breast cancer. Crit. Rev. Oncol. Hematol. [Epub ahead of print], 2012. [Journal] |
|
| 4)
Aprelikova O, Green JE. MicroRNA regulation in cancer-associated fibroblasts. Cancer Immunol. Immunother. 61: 231-7, 2012. [Journal] |
|
| 5)
Switzer CH, Glynn SA, Cheng RY, Ridnour LA, Green JE, Ambs S, Wink DA. S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol. Cancer Res. 10: 1203-15, 2012. [Journal] |
|
| 6)
Hudson TS, Carlson BA, Hoeneroff MJ, Young HA, Sordillo L, Muller WJ, Hatfield DL, Green JE. Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis. Carcinogenesis. 33: 1-6, 2012. [Journal] |
|
| 7)
Rodriguez V, Vasudevan S, Noma A, Carlson BA, Green JE, Suzuki T, Chandrasekharappa SC. Structure-Function Analysis of Human TYW2 Enzyme Required for the Biosynthesis of a Highly Modified Wybutosine (yW) Base in Phenylalanine-tRNA. PLoS ONE. 7: e39297, 2012. [Journal] |
|
| 8)
Green J, Ried T, eds. Genetically-engineered Mice for Cancer Research: design, analysis, pathways, validation and pre-clinical testing. NY: Springer; 2011. [Book (Editor)] |
|
| 9)
Zhu M, Michalowski A, Green J. Green J, Ried T, eds. Expression Profiling of Mouse Models of Human Cancer: model categorization and guidance for preclinical testing. In: Genetically-engineered Mice for Cancer Research: design, analysis, pathways, validation and pre-clinical testing. New York: Springer; 2011. p. 209-234 [Book Chapter] |
|
| 10)
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A, Michalowski A, Green JE. A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients. PLoS ONE. 6: e16694, 2011. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/10/2013.
